» Articles » PMID: 30662289

Ginsenoside Rk1 Ameliorates Paracetamol-induced Hepatotoxicity in Mice Through Inhibition of Inflammation, Oxidative Stress, Nitrative Stress and Apoptosis

Overview
Journal J Ginseng Res
Date 2019 Jan 22
PMID 30662289
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Frequent overdose of paracetamol (APAP) has become the major cause of acute liver injury. The present study was designed to evaluate the potential protective effects of ginsenoside Rk1 on APAP-induced hepatotoxicity and investigate the underlying mechanisms for the first time.

Methods: Mice were treated with Rk1 (10 mg/kg or 20 mg/kg) by oral gavage once per d for 7 d. On the 7th d, all mice treated with 250 mg/kg APAP exhibited severe liver injury after 24 h, and hepatotoxicity was assessed.

Results: Our results showed that pretreatment with Rk1 significantly decreased the levels of serum alanine aminotransferase, aspartate aminotransferase, tumor necrosis factor, and interleukin-1β compared with the APAP group. Meanwhile, hepatic antioxidants, including superoxide dismutase and glutathione, were elevated compared with the APAP group. In contrast, a significant decrease in levels of the lipid peroxidation product malondialdehyde was observed in the ginsenoside Rk1-treated group compared with the APAP group. These effects were associated with a significant increase of cytochrome P450 E1 and 4-hydroxynonenal levels in liver tissues. Moreover, ginsenoside Rk1 supplementation suppressed activation of apoptotic pathways by increasing Bcl-2 and decreasing Bax protein expression levels, which was shown using western blotting analysis. Histopathological observation also revealed that ginsenoside Rk1 pretreatment significantly reversed APAP-induced necrosis and inflammatory infiltration in liver tissues. Biological indicators of nitrative stress, such as 3-nitrotyrosine, were also inhibited after pretreatment with Rk1 compared with the APAP group.

Conclusion: The results clearly suggest that the underlying molecular mechanisms in the hepatoprotection of ginsenoside Rk1 in APAP-induced hepatotoxicity may be due to its antioxidation, antiapoptosis, anti-inflammation, and antinitrative effects.

Citing Articles

Bifidobacterium bifidum reduces oxidative stress and alters gut flora to mitigate acute liver injury caused by N-acetyl-p-aminophenol.

Yin J, Chen L, Lin Y, Qiu J, Liu F, Wang Y BMC Microbiol. 2025; 25(1):87.

PMID: 40000948 PMC: 11853282. DOI: 10.1186/s12866-025-03775-1.


Ginsenoside Rk2 alleviates hepatic ischemia/reperfusion injury by enhancing AKT membrane translocation and activation.

Shen H, Fu J, Liu J, Zou T, Wang K, Zhang X MedComm (2020). 2025; 6(1):e70047.

PMID: 39811799 PMC: 11731106. DOI: 10.1002/mco2.70047.


Protective effects of Panax ginseng as a medical food against chemical toxic agents: molecular and cellular mechanisms.

Rameshrad M, Naraki K, Memariani Z, Hosseinzadeh H Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):8395-8419.

PMID: 38861010 DOI: 10.1007/s00210-024-03186-5.


Comprehensive Investigation of Ginsenosides in the Steamed with Different Processing Conditions Using LC-MS.

Fan J, Liu F, Ji W, Wang X, Li L Molecules. 2024; 29(3).

PMID: 38338369 PMC: 10856252. DOI: 10.3390/molecules29030623.


Natural Products for Acetaminophen-Induced Acute Liver Injury: A Review.

Li X, Lao R, Lei J, Chen Y, Zhou Q, Wang T Molecules. 2023; 28(23).

PMID: 38067630 PMC: 10708418. DOI: 10.3390/molecules28237901.


References
1.
Kim W, Kim J, Han S, Lee S, Kim N, Park M . Steaming of ginseng at high temperature enhances biological activity. J Nat Prod. 2001; 63(12):1702-4. DOI: 10.1021/np990152b. View

2.
Park I, Piao L, Kwon S, Lee Y, Cho S, Park M . Cytotoxic dammarane glycosides from processed ginseng. Chem Pharm Bull (Tokyo). 2002; 50(4):538-40. DOI: 10.1248/cpb.50.538. View

3.
Park I, Kim N, Han S, Kim J, Kwon S, Kim H . Three new dammarane glycosides from heat processed ginseng. Arch Pharm Res. 2002; 25(4):428-32. DOI: 10.1007/BF02976595. View

4.
Dargan P, Jones A . Paracetamol: balancing risk against benefit. QJM. 2002; 95(12):831-2. DOI: 10.1093/qjmed/95.12.831. View

5.
Liu J, Li C, Waalkes M, Clark J, Myers P, Saavedra J . The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in mice. Hepatology. 2003; 37(2):324-33. DOI: 10.1053/jhep.2003.50063. View